Passionate about patients: striving to improve treatments, daring to cure

We start at the beginning of biotech company creation, with scientists and their scientific hypotheses focused on unearthing breakthroughs in human health. We stay involved from the early science to preclinical development, into the clinic and onto the market.

From the Oxford vaccine to new treatments for diseases with limited therapeutic options, we back innovative platform technologies, novel classes of biologics and small molecule therapeutics, vaccines, and cell and gene therapies.